Cyprus Mail

Plant of the Week: Fruits eaten with souvlaki from plant used for genito-urinary problems

Rhus trilobata is common in dry open settings.

Name: Sumach (Rhus aromatica)

Otherwise known as: Sweet Sumach, Staghorn Sumach

Habitat: A deciduous shrub member of the Anacardiaceae family growing to about 5m in dry, open scrubland and native to North America. The bark is usually grey and sometimes dull red, with brownish stems carrying opposed lanceolate leaves, terminating in dense red panicles of flowers which produce sour red berries that are covered in crimson hairs.

What does it do: In herbal medicine Sumach is used primarily to treat infections of the genito-urinary system such as urinary incontinence and frequency; blood in the urine; inflammation of the bladder, rectum and colon; colitis, diverticulosis (pouching or blow-out of the colon), irritable bowel syndrome, bed-wetting and menopausal flooding. In the United States it is claimed that sumach will lower blood sugar and is employed to combat late onset diabetes. The plant was much favoured by the Eclectics, the early pioneer physicians that followed Native American botanical medicine.

The tannic properties of the leaves are used in the leather industry for processing and dyeing; they yield black, grey and yellow dyes. In Cyprus the plant is known as ‘soumaki’ and the dried fruits will often be encountered adorning the ‘souvlaki’ and was also used by the village wise women to treat diarrhea, intestinal infections and some skin disorders.

There are two very poisonous members of this species found in North America: R. venenata and R. toxicodendron which cause swelling of the limbs and sometimes the whole body simply by touching or picking a stem; the swelling is accompanied by intolerable pain.


Related Posts

Willingness to compromise on ‘draconian’ new health law, MPs told  

Elias Hazou

Over 1.2 mln people died from drug-resistant infections in 2019

Reuters News Service

Coronavirus: Virus leaves antibodies that may attack healthy tissues

Reuters News Service

US FDA backs Pfizer’s COVID-19 booster shot for 12- to 15-year-olds (Updated)

Reuters News Service

How long does it take to recover from an athletic injury?

CM Guest Columnist

Conditions at Athalassa ‘at breaking point’

Elias Hazou